From: Cohort study investigating gout flares and management in UK general practice
Hazard ratio for flares (95%CI) | P | Odds Ratio for ULT (95%CI) | P | ||
---|---|---|---|---|---|
Age (25–49 reference) | 50–59 | 0.99 (0.93–1.06) | 0.827 | 0.96 (0.90–1.02) | 0.168 |
60–69 | 1.07 (1.00–1.14) | 0.037 | 0.87 (0.82–0.94) | < 0.001 | |
70–79 | 1.10 (1.02–1.18) | 0.011 | 0.73 0.68–0.79) | < 0.001 | |
80 + | 1.00 (0.92–1.09) | 0.988 | 0.50 (0.45–0.55) | < 0.001 | |
Sex (ref male) | Female | 0.69 (0.66–0.73) | < 0.001 | 0.83 (0.78–0.88) | < 0.001 |
Ethnicity (ref White) | Black | 1.16 (1.08–1.25) | < 0.001 | 1.06 (0.97–1.15) | 0.193 |
South Asian | 1.00 (0.85–1.18) | 0.967 | 0.83 (0.69–1.00) | 0.047 | |
Mixed Race | 0.86 (0.60–1.24) | 0.419 | 0.91 (0.58–1.41) | 0.658 | |
Other | 1.13 (0.98–1.30) | 0.085 | 0.97 (0.83–1.14) | 0.735 | |
Missing | 1.01 (0.97–1.05) | 0.601 | 0.93 (0.88–0.99) | 0.017 | |
IMD (ref 1st (least deprived) decile) | 2 | 1.07 (0.97–1.17) | 0.159 | 1.00 (0.89–1.12) | 0.967 |
3 | 1.00 (0.91–1.09) | 0.953 | 1.06 (0.93–1.20) | 0.381 | |
4 | 1.08 (0.98–1.19) | 0.142 | 1.10 (0.97–1.25) | 0.121 | |
5 | 1.14 (1.02–1.28) | 0.020 | 1.18 (1.02–1.35) | 0.025 | |
Missing | 1.14 (1.06–1.22) | < 0.001 | 1.36 (1.22–1.51) | < 0.001 | |
BMI kg/m2 (ref 20–24.9) | < 20 | 0.95 (0.77–1.17) | 0.647 | 0.85 (0.69–1.05) | 0.126 |
25–29.9 | 1.10 (1.04–1.17) | 0.001 | 1.21 (1.13–1.30) | < 0.001 | |
30–34.9 | 1.18 (1.10–1.25) | < 0.001 | 1.27 (1.18–1.37) | < 0.001 | |
35 + | 1.36 (1.27–1.47) | < 0.001 | 1.34 (1.24–1.45) | < 0.001 | |
Missing | 1.14 (1.04–1.25) | 0.006 | 1.11 (1.00–1.23) | 0.042 | |
Alcohol units per week (ref 0) | 1–9 | 0.98 (0.91–1.06) | 0.668 | 0.77 (0.70–0.85) | < 0.001 |
10–24 | 0.98 (0.91–1.06) | 0.606 | 0.81 (0.74–0.89) | < 0.001 | |
25–42 | 1.09 (0.99–1.19) | 0.091 | 0.84 (0.75–0.94) | 0.003 | |
> 42 | 1.11 (0.97–1.26) | 0.117 | 0.79 (0.69–0.91) | 0.001 | |
Missing | 0.99 (0.92–1.06) | 0.784 | 0.82 (0.75–0.89) | < 0.001 | |
Hypertension | 1.09 (1.03–1.14) | 0.001 | 1.03 (0.98–1.08) | 0.265 | |
Type 1 diabetes | 0.96 (0.73–1.25) | 0.757 | 0.93 (0.69–1.25) | 0.626 | |
Type 2 diabetes | 1.04 (0.97–1.10) | 0.255 | 0.86 (0.80–0.92) | < 0.001 | |
Heart Failure | 1.38 (1.27–1.49) | < 0.001 | 1.44 (1.29–1.59) | < 0.001 | |
CVD | 1.22 (1.15–1.31) | < 0.001 | 0.97 (0.91–1.04) | 0.433 | |
Diuretics | 1.18 (1.12–1.24) | < 0.001 | 1.27 (1.20–1.35) | < 0.001 | |
Aspirin | 0.96 (0.91–1.03) | 0.242 | 1.11 (1.04–1.19) | 0.002 | |
CKD (ref none) | CKD Stage 3 | 1.33 (1.26–1.40) | < 0.001 | 1.51 (1.42–1.60) | < 0.001 |
CKD stage 4 | 1.37 (1.19–1.56) | < 0.001 | 1.87 (1.59–2.21) | < 0.001 | |
CKD stage 5 | 1.08 (0.86–1.35) | 0.493 | 1.55 (1.23–1.96) | < 0.001 | |
Serum urate µmol/L (ref < 360) | 360–419 | 1.91 (1.65–2.22) | < 0.001 | 2.74 (2.34–3.21) | < 0.001 |
420–479 | 2.64 (2.31–3.01) | < 0.001 | 4.49 (3.85–5.23) | < 0.001 | |
480–539 | 3.43 (3.00–3.92) | < 0.001 | 6.83 (5.86–7.96) | < 0.001 | |
≥ 540 | 4.63 (4.03–5.31) | < 0.001 | 11.16 (9.56–13.04) | < 0.001 | |
Missing | 2.62 (2.30–2.98) | < 0.001 | 4.02 (3.45–4.69) | < 0.001 | |
Number of flares | - | - | 1.43 (1.38–1.48) | < 0.001 |